Eugenio Cingolani, MD
@eugeniocingolan
Associate Professor. Director Cardiogenetics Program & PreClinical Research - Cardiac Electrophysiology - Tweets = Own
ID: 626669524
https://www.cedars-sinai.edu/research/labs/cingolani.html 04-07-2012 18:16:50
4,4K Tweet
3,3K Followers
1,1K Following
Webinar de Amiloidosis cardíaca de SIAC Miocardiopatías ❤️🌎 Inscripción free ⤵️ siacardio.com/amiloidosissiac 📅 20 de noviembre -19 hs Argentina, Uruguay, Brasil y Chile -16 hs México, Costa Rica y Guatemala -17 hs Colombia, Ecuador, Panamá y Perú -18 hs República Dominicana y Venezuela
A hungry heart muscle cell (cardiac myocyte) videoed through a microscope by Burnette Lab graduate student, Emma Koory. What is it eating and why? We may never know....... #CellBiology
Congrats Saman Nazarian, MD, PhD and colleagues! More evidence that hyperboloids do exist #VTin3D. Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy | Circulation ahajournals.org/doi/10.1161/CI…
Adult heart transplantation in the USA and Western Europe. Read this State-of-the-Art review in #EHJ 👉 ow.ly/iemR50Xtktq Rocco Montone @ehj_edehj
We had a wonderful time at #APHRS! It was a great opportunity to catch up with inHEART users from across the Asia-Pacific region and explore new, innovative ways to advance cardiac care together. Huge congratulations to Dr. Hachisuka Masato for his presentation on Peak Frequency
#ICYMI #OriginalResearch After a heart attack, fibroblasts can transform into fat cells via disrupted TGF-β signaling, driving lipomatous metaplasia—shedding new light on post-MI remodeling! ahajrnls.org/48kU3qL Izabela Tuleta Albert Einstein College of Medicine - Official D. Zheng
In this #JACCBTS article, Prof Livia Hool and colleagues provide evidence that variant peptides targeting L-type calcium channels prevent the development of hypertrophic cardiomyopathy in mice. Read more: bit.ly/47R5Zz5 #HeartFailure #cvHCM
Plozasiran (APOC3 siRNA, REDEMPLO) is now FDA-approved as an adjunct to diet to reduce triglycerides among patients with familial chylomicronemia syndrome. And congrats to ArrowheadPharma on their first FDA-approved medicine! arrowheadpharma.com/news-press/arr…